Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03145701 · ClinicalTrials.gov registry record

Doppler Flow Wires in Cerebral Angiography

A clinical trial of Aneurysm and Cerebral Aneurysm, sponsored by University of Washington.

Completed
Registry status
117
Enrollment target
1
Study location

NCT03145701 is a study of Aneurysm and Cerebral Aneurysm that has completed, run by University of Washington. The registered enrollment target is 117 participants, below the 17,077-participant average among 6 other Aneurysm trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03145701, a study of Aneurysm and Cerebral Aneurysm, has completed, sponsored by University of Washington.

COMPLETED
Registry status
117 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to use a wire with a Doppler tip to measure blood flow in vessels in the brain and determine hemodynamic factors associated with treatment success or failure. Many neurological diseases cause abnormal blood flow in the brain in specific vessels. The special wire used in this study is place into brain blood vessels during standard of care procedure to treat such diseases, and blood flow parameters (such as velocity and pressure) are measured to gain better understanding of these neurological diseases.

Study Locations (1)

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2020-06-01
Est. Completion 2020-06-01

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT03145701

The ClinicalTrials.gov registry entry for NCT03145701 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 17,077-participant average among 6 other Aneurysm trials with a reported enrollment target (99% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Aneurysm appearing as the primary indexed condition, and to 0 interventions.

NCT03145701 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT03145701 about?

NCT03145701 is a clinical study titled "Doppler Flow Wires in Cerebral Angiography". The purpose of this study is to use a wire with a Doppler tip to measure blood flow in vessels in the brain and determine hemodynamic factors associated with treatment success or failure. Many neurological diseases cause abnormal blood flow in the brain in specific vessels. The special wire used in ...

What is the current status of trial NCT03145701?

This trial is currently completed. The enrollment target is 117 participants. The study started on 2020-06-01. Estimated completion is 2020-06-01.

What conditions does trial NCT03145701 study?

This clinical trial studies the following conditions: Aneurysm, Cerebral Aneurysm.

Who is sponsoring clinical trial NCT03145701?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03145701 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.